  Diabetes is a major public health challenge worldwide. Abnormal physiology in
diabetes, particularly hypoglycemia, can cause driver impairments that affect
safe driving. While diabetes driver safety has been previously researched, few
studies link real-time physiologic changes in drivers with diabetes to
objective real-world driver safety, particularly at high-risk areas like
intersections. To address this, we investigated the role of acute physiologic
changes in drivers with type 1 diabetes mellitus (T1DM) on safe stopping at
stop intersections. 18 T1DM drivers (21-52 years, mean = 31.2 years) and 14
controls (21-55 years, mean = 33.4 years) participated in a 4-week naturalistic
driving study. At induction, each participant's vehicle was fitted with a
camera and sensor system to collect driving data. Video was processed with
computer vision algorithms detecting traffic elements. Stop intersections were
geolocated with clustering methods, state intersection databases, and manual
review. Videos showing driver stop intersection approaches were extracted and
manually reviewed to classify stopping behavior (full, rolling, and no stop)
and intersection traffic characteristics. Mixed-effects logistic regression
models determined how diabetes driver stopping safety (safe vs. unsafe stop)
was affected by 1) disease and 2) at-risk, acute physiology (hypo- and
hyperglycemia). Diabetes drivers who were acutely hyperglycemic had 2.37
increased odds of unsafe stopping (95% CI: 1.26-4.47, p = 0.008) compared to
those with normal physiology. Acute hypoglycemia did not associate with unsafe
stopping (p = 0.537), however the lower frequency of hypoglycemia (vs.
hyperglycemia) warrants a larger sample of drivers to investigate this effect.
Critically, presence of diabetes alone did not associate with unsafe stopping,
underscoring the need to evaluate driver physiology in licensing guidelines.
